Physician profile
Christopher Colasanti
NPI 1902461064
$4,163.13
in general payments reported to CMS, 2019-2025
7 companies · $4,163 in 2025
The $4,163 reported for 2025 was more than what 79% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $4,163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,228 · Food and Beverage: $1,553 · Education: $383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,227.77 |
| Food and Beverage | $1,552.72 |
| Education | $382.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exactech, INC. | $1,975.21 | 2025 | |
| Arthrex, INC. | $1,340.89 | 2025 | |
| Zimmer Biomet Holdings, INC. | $523.04 | 2025 | Comprehensive Shoulder System, Nexel, Comprehensive |
| Stryker Corporation | $239.37 | 2025 | Aequalis Perform Reversed, Mako |
| Southern Edge Orthopaedics, INC. | $37.60 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $25.94 | 2025 | Zilretta, Iovera, Exparel |
| Paladin Technology Solutions | $21.08 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Colasanti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.